A dedicated Phase 3 trial evaluating retatrutide specifically for metabolic dysfunction-associated steatotic liver disease is currently underway
People are hearing strong trial results, seeing scattered prices online, and trying to compare an investigational treatment with approved medications that already have set pharmacy pathways
The combination of GLP-1's effect on insulin sensitivity and strength trainings ability to improve it can create a synergistic effect, making the body more efficient at using glucose and promoting fat loss while preserving muscle
The percentages above are from separate trials with different populations and durations, so direct comparison requires caution
Mitigation strategies include strict adherence to the titration schedule, eating smaller and more frequent meals, avoiding high-fat and greasy foods, staying well hydrated, and eating slowly
From pharmacy to pantry How GLP-1 drugs are shifting consumer preferences and shopping patterns Wells Fargo Agri-Food Institute digs into the data with NielsenIQ on GLP-1 use, consumer purchase trends, and how companies can tip the scales in favor of more profitability